Abstract
The relationship between the metabolites of glycyrrhizin (18β-glycyrrhetinic acid-3-O-β-d-glucuronopyranosyl-(1→2)-β-d-glucuronide, GL) and their biological activities was investigated. By human intestinal microflora, GL was metabolized to 18β-glycyrrhetinic acid (GA) as a main product and to 18β-glycyrrhetinic acid-3-O-β-d-glucuronide (GAMG) as a minor product. The former reaction was catalyzed byEubacterium L-8 and the latter was byStreptococcus LJ-22. Among GL and its metabolites, GA and GAMG had more potentin vitro anti-platelet aggregation activity than GL. GA also showed the most potent cytotoxicity against tumor cell lines and the potent inhibitory activity on rotavirus infection as well as growth ofHelicobacter pylori. GAMG, the minor metabolite of GL, was the sweetest.
Similar content being viewed by others
References
Abe, N., Ebina T., Ishida N., Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice.Microbiol. Immunol., 26, 535–539 (1982).
Akao T., Akao, T., Kobashi K., Glycyrrhizin β-D-glucu-ronidase of Eubacterium sp. from human intestinal flora.Chem. Pharm. Bull., 35, 705710 (1987).
Akao, T., Akao, T., Hattori, M., Kanaoka M., Yamamoto K., Namba T., Kobashi, K., Hydrolysis of glycyrrhizin to 18β-glycyrrhetinyl monoglucuronide by lysosomal-D-glucuronidase of animal livers.Biochem. Pharmacol., 41, 1025–1029 (1991).
Bae E.-A., Han, M. J., Kim, N.-J., Kim, D.-H., Anti-Helicobacter pylori activity of herbal medicines.Biol. Pharm. Bull., 21, 990–992 (1998).
Brieskorn C. H., Lang, J., 18β-Glycyrrhetinsaure und suer Geschmack.Arch. Pharm. (Weinheim) 311, 1001–1009 (1978).
Carmichael J., DeGreff W. G., Gazdar A. F., Minna J. D., Mitchell J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.Cancer Res., 47, 936–942 (1987).
Gutmann I., Bergmeyer H. U., Urea in Methods of Enzymatic Analysis, Vol. ed. by Bergmeyer H. U., Academic press Inc., New York, pp. 1791–1794 (1974).
Hattori M., Sakamoto T., Kobashi K., Namba, T., Metabolism of glycyrrhizin by human intestinal flora.Planta Med., 48, 38–42 (1983).
Kim D.-H., Jang I.-S., Lee H.-K., Jung, E.-A., Lee, K.-Y., Metabolism of glycyrrhizin and baicalin by human intestinal bacteria.Arch. Pharm. Res., 19, 292–296 (1996).
Kim D.-H., Jang I.-S.,Bacteroides J-37, a human intestinal bacterium, produces β-glucuronidase.Biol. Pharm. Bull., 20, 834–847 (1997).
Kim D.-H., Lee, S.-W., Han, M.J., Biotransformation of glycyrrhizin to 18-glycyrrhetinic acid 3-O-β-D-glucuronide byStreptococcus LJ-22, a human intestinal bacteria.Biol. Pharm. Bull., 22, 320–322 (1999).
Kumagai A., Yano M., Otomo M., Tekuchi K., Study on the corticoid-like action of glycyrrhizin and mechanism of its action.Endocrinol. Jpn., 4, 17–27 (1957).
Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J., Protein measurement with the folin pheol reagent.J. Biol. Chem., 193, 165–275 (1951).
Moore W. E. C. and Moore L. V. H., “Bergey’s Manual of Systemic Bacteriology,” ed. by Holt J. G., Williams and Wilkins, Baltimore, pp. 1353–1373 (1984).
Nakano N., Kato H., Suzuki H., Nakano N., Yano S., Kanaoka, M., Enzyme immunoassay of glycyrrhetinic acid and glycyrrhizin II. Measurement of glycyrrhetinic acid and glycyrrhizin in serum.Jpn. Pharmacol. Ther., 8, 4171–4174 (1980).
Pompeo R., Flore O., Marccialis M. A., Pani A., Loddo B., Glycyrrhizic acid inhibits virus growth and inactivates virus particles.Nature (London), 281, 689–690 (1979).
Song M.-J., Kim D.-H., Inhibitory effect of herbal medicines on Rotavirus infection.Kor. J. Pharmacogn., 29, 125–128 (1998).
Yun-Choi H. S, Kim, S. O., Kim, J. H., Lee J. R., Cho H. J., Modified smear method form screening potential inhibitors of platelet aggregation from plant sources.J. Nat. Prod., 48, 363–370 (1985).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, DH., Hong, SW., Kim, BT. et al. Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities. Arch Pharm Res 23, 172–177 (2000). https://doi.org/10.1007/BF02975509
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02975509